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Communication of antibiotic resistance among bacteria via small molecules is implicated in 25 
transient reduction of bacterial susceptibility to antibiotics, which could lead to therapeutic 26 
failures aggravating the problem of antibiotic resistance. Released putrescine from the extremely 27 
antibiotic resistant bacterium Burkholderia cenocepacia protects less resistant cells from 28 
different species against the antimicrobial peptide polymyxin B (PmB). Exposure of B. 29 
cenocepacia to sub-lethal concentrations of PmB and other bactericidal antibiotics induce 30 
reactive oxygen species (ROS) production and expression of the oxidative stress response 31 
regulator OxyR. We evaluated whether putrescine alleviates antibiotic-induced oxidative stress. 32 
The accumulation of intracellular ROS such as superoxide ion and hydrogen peroxide was 33 
assessed fluorometrically with dichlorofluorescein diacetate, while the expression of OxyR and 34 
putrescine synthesis enzymes was determined in luciferase assays using chromosomal promoter-35 
lux reporter system fusions. We evaluated wild type and isogenic deletion mutant strains with 36 
defects in putrescine biosynthesis after exposure to sub-lethal concentrations of PmB and other 37 
bactericidal antibiotics. Exogenous putrescine protected against oxidative stress induced by PmB 38 
and other antibiotics, whereas reduced putrescine synthesis resulted in increased ROS 39 
generation, and a parallel increased sensitivity to PmB. Of the 3 B. cenocepacia putrescine 40 
synthesizing enzymes, PmB induced only BCAL2641, an ornithine decarboxylase. This study 41 
exposes BCAL2641 as a critical component of the putrescine-mediated communication of 42 
antibiotic resistance, and as a plausible target for designing inhibitors that would block the 43 
communication of such resistance among different bacteria, ultimately reducing the window of 44 
therapeutic failure in treating bacterial infections. 45 
 46 
47 
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INTRODUCTION 48 
The relentless increase in multidrug resistance, particularly intrinsic, high-level resistance, 49 
undermines new treatments improving health and extending the life of patients especially of 50 
those with chronic conditions (1). For example, respiratory failure secondary to chronic 51 
pulmonary bacterial infection in patients with cystic fibrosis hinders the dramatic improvements 52 
in survival achieved over the last several decades and remains the primary cause of death (2). 53 
The emergence of growing numbers of cystic fibrosis pathogens with intrinsic, multidrug 54 
resistance such as Burkholderia cepacia complex, Stenotrophomonas maltophilia, 55 
Achromobacter xylosoxidans, and nontuberculous mycobacteria creates a further need for novel 56 
therapies (2). We investigate the mechanisms of high-level intrinsic multidrug resistance using 57 
Burkholderia cenocepacia as a model bacterium. B. cenocepacia is an environmental, 58 
opportunistic pathogen that belongs to the B. cepacia complex and causes serious respiratory 59 
infections in CF patients (3). These infections are associated with faster decline in lung function, 60 
debilitating exacerbations and ultimately death (4-6), and they also reduce the survival of CF 61 
patients after lung transplant (7). 62 
 While genetic mechanisms are considered the quintessential means of transfer of antibiotic 63 
resistance traits among bacteria, small molecules are also capable of modulating the antibiotic 64 
response of bacteria (8). The clinical outcome of antibiotic treatment does not always correlate 65 
with the expectations based on in vitro susceptibility testing performed on individual clinical 66 
isolates (9). Owing to the polymicrobial nature of many infections (10), cross-talk between the 67 
different bacterial species is likely to occur during infection. Such chemical communication of 68 
antibiotic resistance among bacteria may aggravate the problem of antibiotic resistance by 69 
potentially causing transient reduction in the susceptibility to antibiotics, potentially leading to 70 
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therapeutic failures. For example, a transient increase in resistance to antimicrobial peptides by 71 
exposure to host polyamines was shown for the urogenital pathogen Neisseria gonorrhoeae (11). 72 
Identifying chemical communicators of antibiotic resistance and their mechanism of protection 73 
would provide another avenue for intervention to combat the increase and spread of 74 
antimicrobial resistance. Recently, we demonstrated that B. cenocepacia exhibits a non-genetic 75 
mechanism to reduce antibiotic susceptibility that is chemically mediated by putrescine and 76 
YceI, a small secreted protein of unknown function that is highly conserved in bacteria (12). 77 
Putrescine is a polyamine produced by almost all living organisms (13). When released from B. 78 
cenocepacia, putrescine protects less resistant cells from the same and different species from the 79 
antimicrobial peptide polymyxin B (PmB) (12). 80 
 The mechanism of protection is partly due to the ability of putrescine to compete with PmB 81 
for binding to the surface of B. cenocepacia (12). However, polyamines can also quench 82 
oxidative species (14) and protect membranes from lipid peroxidation (15). Various classes of 83 
antibiotics induce oxidative stress and increased production of reactive oxygen species (ROS) 84 
(16-19). Although the specific lethal role of ROS generated in response to antibiotics remains 85 
under discussion (16, 20, 21), oxidative stress constitutes a burden on the bacterial cells (22).  86 
Therefore, it is conceivable that protection from oxidative stress accompanying antibiotic 87 
exposure would improve the bacterial response to antibiotics, thus increasing resistance. 88 
 Here we show that when present at sub-lethal concentrations, PmB and other bactericidal 89 
antibiotics induce oxidative stress in B. cenocepacia. Our findings revealed that exogenous and 90 
endogenous putrescine protects against antibiotic-mediated oxidative stress. This work exposes 91 
another mechanism of putrescine-mediated protection from antibiotics alongside with protection 92 
of cell surface from binding of PmB previously described (12). By examining the expression 93 
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patterns of the different putrescine synthesizing enzymes in response to antibiotics, we 94 
discovered that the ornithine decarboxylase BCAL2641 is a plausible target for designing 95 
inhibitors that would block putrescine-mediated communication of antibiotic resistance among 96 
different bacteria, ultimately reducing the window of therapeutic failure in treating bacterial 97 
infections. 98 
99 
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MATERIALS AND METHODS 100 
Strains and reagents. Table 1 lists bacteria and plasmids used in this study. Bacteria grew in LB 101 
at 37°C. Antibiotics (Sigma, St Louis, MO, USA) were diluted in water except for PmB, which 102 
was diluted in 0.2% bovine serum albumin/0.01% glacial acetic acid buffer. Rifampicin was 103 
dissolved in dimethyl sulphoxide (DMSO). 104 
 General molecular techniques. DNA manipulations were performed as previously 105 
described (23). T4 DNA ligase (Roche Diagnostics, Laval, Quebec, Canada), Antarctic 106 
phosphatase (New England Biolabs, Pickering, Ontario, Canada) and restriction endonucleases 107 
(Roche or New England Biolabs) were used as recommended by the manufacturers. 108 
Transformation of Escherichia coli GT115 was performed using the calcium chloride method 109 
(24). Mobilization of plasmids into B. cenocepacia was conducted by triparental mating (25) 110 
using E. coli DH5α carrying the helper plasmid pRK2013 (26). DNA amplification by 111 
polymerase chain reaction (PCR) was performed using a C1000 Thermal cycler (Bio-Rad 112 
Laboratories Ltd., Mississauga, Ontario, Canada) with Taq or HotStar HiFidelity DNA 113 
polymerases (Qiagen, Mississauga, Ontario, Canada) and optimized for each primer pair. DNA 114 
sequencing was carried out at the DNA sequencing Facility of York University, Toronto, Canada 115 
or at Eurofins MWG Operon, Huntsville, Alabama, USA. The DNA sequences were analyzed 116 
with the BLAST computer program and compared to the sequenced genome of B. 117 
cenocepacia strain J2315. 118 
 Fluorometric determination of ROS. Overnight cultures of the parental B. cenocepacia 119 
K56-2 and the appropriate mutants in LB medium were diluted to an optical density at 600 nm 120 
(OD600) of 0.1 in fresh medium. Five-ml aliquots were incubated at 37oC for 3 h at 200 rpm. 121 
Antibiotics and/or putrescine were added at the specified concentrations and the cultures were 122 
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further incubated at 37oC for 2 h at 200 rpm. After incubation, the OD600 was measured and 123 
aliquots containing cells equivalent to an OD600 of 0.4 were pelleted, washed with phosphate 124 
buffered saline (PBS), and resuspended in 1 ml of PBS. Superoxide radicals and other ROS were 125 
determined by diluting the obtained suspension 100 fold in 1 ml PBS and adding 2’,7’-126 
dichlorofluorescein diacetate (DCF) to a final concentration of 2 µM. The reaction mixture was 127 
then incubated at 37oC for 30 min with rotation. After incubation, the fluorescence was measured 128 
in 200-µl aliquots placed into 96-well white plates (Microfluor-2 White, Thermo Scientific) at 129 
λex= 480 nm and λem= 521 nm, using Cary Eclipse fluorescence spectrophotometer (Varian, Inc., 130 
Mississauga, Ontario, Canada). In addition, the OD600 of the same suspensions were measured 131 
and used to normalize the fluorescence values. Hydroxyl radical production was determined in 132 
600 µl bacterial suspensions without dilution using 3’-(p-hydroxyphenyl) fluorescein (HPF) at a 133 
final concentration of 5 µM. Fluorescence was measured at λex= 495 nm and λem= 530 nm in 200 134 
µl aliquots placed into 96-well white plates. Background fluorescence of each probe in buffer 135 
control was subtracted. Autofluorescence of the bacterial suspensions, without adding the probes, 136 
was measured and corrected for by subtraction from the fluorescence signals. Data were 137 
normalized to the OD600 of the bacterial suspensions. The suspensions were protected from light 138 
throughout the assays to avoid photo-oxidation. 139 
 Antibiotic susceptibility testing. Overnight cultures of the parental B. cenocepacia K56-2 140 
and the appropriate mutants in LB medium were diluted to an optical density at 600 nm (OD600) 141 
of 0.0008 (low inoculum) or 0.04 (high inoculum) in fresh LB medium and 0.04 in fresh M9 142 
minimal medium with or without the antibiotic and incubated at 37°C with medium continuous 143 
shaking in a Bioscreen C automated growth curve analyzer (MTX Lab Systems, Vienna, VA, 144 
USA). Bacterial growth was assessed turbidimetrically at 600 nm. 145 
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 In vitro antioxidant activity assay. The ability of putrescine to scavenge free radicals was 146 
determined using a system of in vitro generation of superoxide radicals containing phenazine 147 
methosulfate (PMS)-NADH as previously described (27). Briefly, the reaction mixture consisted 148 
of 21 mM phosphate buffer (pH 8.3), 0.7 mM NADH, 17 µM nitro blue tetrazolium, and the 149 
corresponding quantity of putrescine. The reaction was initiated by adding 4 µM PMS. The 150 
reaction mixtures were mixed and the amount of formazan formation was measured immediately 151 
using the spectrophotometer at 560 nm. The percentage of inhibition of formazan formation by 152 
putrescine was calculated relative to the control lacking putrescine. 153 
 Transcriptional fusions to luxCDABE. The promoter regions from BCAL2641, 154 
BCAM1111, BCAM1112 and OxyR were PCR amplified. The PCR products were digested with 155 
EcoRI and cloned into the EcoRI digested and dephosphorylated pGSVTp-lux plasmid. The 156 
orientation of the promoter region was checked by PCR and luminescence of E. coli GT115 157 
colonies carrying the plasmids. The resulting plasmids contained the promoter region of the 158 
genes of interest fused to the luxCDABE reporter system. The plasmids were mobilized into 159 
K56-2 and the appropriate mutants by triparental mating. Transconjugants (carrying the 160 
chromosomal promoter-reporter fusions) were selected on LB agar plates containing 100 µg/ml 161 
of trimethoprim (Tp), 200 µg/ml ampicillin and 10 µg/ml gentamicin. 162 
 Luminescence expression assays. Overnight cultures in LB containing 100 µg/ml Tp were 163 
diluted into fresh LB medium to OD600=0.04. After addition of the antibiotics and/or putrescine, 164 
300 µl of sample were loaded in triplicate, for each time-point, in a 100-well honeycomb 165 
microtitre plate. The plates were incubated at 37°C with medium continuous shaking in a 166 
Bioscreen C automated growth curve analyzer (MTX Lab Systems, Vienna, VA, USA). Growth 167 
was followed by measuring the OD600 at 37°C every 30 min. At pre-determined time points post-168 
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inoculation, the Bioscreen was paused and three 200 µl aliquots for each condition tested were 169 
transferred into a flat bottom 96-well microtiter plate (Microfluor-2 White, Thermo Scientific) 170 
and luminescence (in relative light units, RLU) was measured using a Fluoroskan Ascent FL 171 
Microplate Fluorometer and Luminometer (Thermo Scientific, Ottawa, Ontario, Canada). 172 
Expression levels of each gene of interest in the different strain backgrounds were calculated as 173 
RLU/OD600 for each time-point. 174 
Construction of a conditional mutant. A fragment (~300-bp) spanning the 5′ region of 175 
BCAL2641 was PCR amplified, digested by NdeI and XbaI and cloned into the NdeI and XbaI 176 
digested and dephosphorylated pSC200 plasmid. The plasmids were mobilized into OME12 177 
(∆BCAM1111-1112) by triparental mating. Transconjugants were selected on LB agar plates 178 
containing 100 µg/ml of trimethoprim (Tp), 200 µg/ml ampicillin, 10 µg/ml gentamicin and 179 
0.5% (wt/vol) rhamnose. This strategy creates conditional mutants in which the expression of the 180 
targeted gene depended on the rhamnose concentration in the medium (28).  181 
Thin-layer chromatography analyses of polyamines. The conditional mutant and the wild 182 
type were grown at 37°C in M9 minimal medium supplemented with final concentrations of Tp 183 
100 μg/ml and rhamnose 0.4% (wt/vol), permissive condition of expression. An aliquot of an 184 
overnight culture in M9 medium with rhamnose was spun down and washed three times with 185 
sterile phosphate-buffered saline (PBS), resuspended in PBS, and adjusted to an OD600 of 1. 186 
Drops (10 μl) of undiluted suspension and 10-fold serial dilutions were plated onto M9 agar 187 
plates supplemented with 0.4% (wt/vol) glucose and incubated at 37°C (non-permissive 188 
condition of expression). Bacteria growing on the plates were collected, suspended in sterile 189 
PBS, and the OD600 was adjusted to 0.1. Polyamines were extracted, derivatized to their dansyl 190 
derivatives, sequentially separated on TLC silica gel plates (20×20 cm, Merck, Darmstadt, 191 
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Germany) in two solvent systems: I) benzene–triethylamine (20:2 v/v); II) benzene–methanol 192 
(10:0.45 v/v) and visualized under ultraviolet light as previously described (12). Standard 193 
solutions of putrescine, cadaverine, spermidine and spermine (0.2 mM each) were treated 194 
similarly and included as controls. 195 
Catalase enzyme activity assay. Overnight cultures of the wild type B. cenocepacia K56-2 in 196 
LB were diluted to OD600=0.04 into 30 ml fresh LB medium, with or without antibiotics, and 197 
incubated at 37oC, 200 rpm for 16 h. Bacterial cells were pelleted, washed with sterile PBS and 198 
resuspended in 300 µl (or less if necessary depending on bacterial inhibition of growth by 199 
antibiotics) of PBS. The OD600 of the bacterial suspensions was measured. The catalase enzyme 200 
activity was evaluated using the method described by Iwase et al. (29). Briefly, 100 µl of 201 
bacterial suspension or bovine liver catalase solution at different concentrations were added in a 202 
glass tube followed by the addition of 100 µl of 1% Triton X-100. Finally, 100 µl of undiluted 203 
hydrogen peroxide (30%) were added to the solutions, mixed thoroughly and incubated at room 204 
temperature. The height of O2-forming foam that remained constant for 15 min in the test tube 205 
was finally measured using a ruler. The catalase activity of bacterial suspensions was determined 206 
using calibration curves constructed using the standard catalase solutions with different 207 
concentrations and normalized to the OD600 of the tested suspensions. 208 
  Statistical Analyses. Unpaired student’s t-tests were conducted with GraphPad Prism 5.0. 209 
210 
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RESULTS AND DISCUSSION 211 
Putrescine reduces ROS production induced by PmB. Treatment of B. cenocepacia K56-2 212 
with 1 mg/ml PmB led to significantly increased production of intracellular ROS, as detected by 213 
2’,7’-dichlorofluorescein diacetate (DCF) (Fig. 1). DCF is a colorless, nonfluorescent fluorescein 214 
derivative which passively diffuses into cells where the two acetate groups are cleaved by 215 
intracellular esterases to yield the non-cell permeable 2’, 7’- dichlorofluorescein (30). This 216 
cleaved product becomes trapped within the cells and becomes oxidized by intracellular ROS 217 
resulting in the formation of a highly fluorescent product; hence it is a measure of generalized 218 
oxidant production rather than that of any particular reactive species (30).  Lower concentrations 219 
of PmB (0.5 mg/ml or less) did not alter the intracellular DCF-detectable ROS pool (data not 220 
shown), whereas due to its reduced solubility in the culture medium higher concentrations of 221 
PmB could not be reliably tested. Since putrescine protects B. cenocepacia from PmB (12), we 222 
assessed whether it also alleviates PmB-induced ROS production. Compared to control cells, 223 
exogenous putrescine reduced DCF-detectable ROS generation in PmB-treated bacteria (Fig. 1). 224 
This effect was assessed at 2 h incubation with PmB and/or putrescine to avoid potential 225 
interference from putrescine degradation or metabolic by-products at prolonged incubation 226 
times. It should be noted that putrescine did not decrease the background ROS levels produced 227 
by bacterial cells not exposed to PmB, but rather caused a slight but significant increase in DCF-228 
detected ROS levels compared to control cells at 20 mM (Fig. 1, white bars). We attributed these 229 
results to polyamines catabolism, which also generate ROS (31). 230 
 To assess whether endogenous putrescine also has the ability to reduce ROS levels in PmB-231 
treated B. cenocepacia, we employed deletion mutants in the putrescine biosynthesis pathway. 232 
Putrescine can arise through the action of either ornithine decarboxylase or arginine 233 
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decarboxylase (12). B. cenocepacia has two ornithine decarboxylase homologues, BCAL2641 234 
and BCAM1111, and one arginine decarboxylase protein, BCAM1112 (Fig. 2A). The ornithine 235 
decarboxylase BCAL2641 is encoded by a gene located on chromosome 1 of B. cenocepacia; 236 
whereas both the ornithine decarboxylase BCAM1111 and the arginine decarboxylase 237 
BCAM1112 are encoded by genes located adjacent to each other, but in opposite orientation, on 238 
chromosome 2. In a previous study, we have shown that ∆BCAL2641 had a greater reduction in 239 
the amount of secreted putrescine compared to wild type than ∆BCAM1111-BCAM1112 (12). 240 
Here, we confirmed that these three enzymes are the only contributors to putrescine production 241 
in B. cenocepacia. A conditional mutant of BCAL2641 in the ∆BCAM1111-BCAM1112 242 
background did not produce detectable levels of putrescine at the non-permissive conditions of 243 
expression compared to the wild type strain (Fig. 2B). With respect to the response to PmB, the 244 
ornithine decarboxylase BCAL2641 was the only enzyme, among the 3 putrescine synthesis 245 
enzymes, involved in resistance against PmB. ∆BCAL2641, but not ∆BCAM1111-BCAM1112, 246 
had increased susceptibility to PmB compared to wild type when tested in LB medium (Fig. 2C 247 
and 2D) or M9 medium (Fig. 2E). Although the growth of ∆BCAM1111-BCAM1112 was not 248 
impaired in LB medium regardless of the initial inoculum size (Fig. 2C and 2D), it exhibited 249 
significant reduction in growth compared to the wild type cells in M9 medium (Fig. 2E). 250 
Nevertheless, this mutant did not show increased susceptibility to PmB in M9 medium in which 251 
its growth was retarded (Fig. 2E). On the contrary, ∆BCAL2641 showed slight reduction in 252 
growth in LB medium only at low inoculum size (Fig. 2C) but not at high inoculum size (Fig. 253 
2D) or in M9 medium (Fig. 2E). This suggests that these genes involved in putrescine synthesis 254 
are not functionally redundant; they seem to be stimulated under different conditions and 255 
regulated differently with BCAL2641 only involved in resistance to antibiotics. Next, detection 256 
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of ROS by DCF was assessed after incubation of ∆BCAL2641 and ∆BCAM1111-BCAM1112 257 
mutants with PmB for 16 h to allow the different enzymes to reach their maximum expression 258 
levels which occurred at about 12 h in the luminescence expression assays (not shown). No 259 
differences were observed in PmB-untreated cells between the wild type and the deletion 260 
mutants (Fig. 3, white bars). In contrast, ∆BCAL2641 exhibited a significant increase in levels of 261 
superoxide and other ROS detected by DCF in response to PmB compared to wild type, whereas 262 
∆BCAM1111-BCAM1112 produced the same level as that in the parental strain (Fig. 3). 263 
Together, these results support the notion that putrescine reduces the level of PmB-induced ROS 264 
production and this reduction contributes to protection of bacteria from the bactericidal effects of 265 
PmB. 266 
 Hydroxyl radical is another ROS that may be produced upon oxidative stress. Others have 267 
used hydroxyphenyl fluorescein (HPF) to fluorometrically detect hydroxyl radicals upon 268 
antibiotic stress (16). Using HPF in similar experiments as above, we found a comparable pattern 269 
of reduction of PmB-induced ROS by putrescine (data not shown). However, the fluorescence 270 
signal detected by HPF was too low compared to that detected by DCF, and required 100-fold 271 
higher inoculum than that for the DCF experiments to detect signal above the background noise 272 
of fluorescence. Such high inoculum of cells led to high autofluorescence compared to the actual 273 
fluorescence signal detected upon adding HPF, which was not the case with the DCF assays (Fig. 274 
S1). Thus, we disregarded the results of HPF assays. Similar criticism to the use of HPF was 275 
raised recently concerning the interference between the autofluorescence of cells with the actual 276 
fluorescence in the presence of the probe especially upon antibiotic treatment (32). 277 
Although the DCF fluorometric assay is a well established method and has many advantages 278 
over other techniques developed for measurement of intracellular ROS (30), the probe may be 279 
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nonselective reacting with other oxidants such as hydroxyl radicals and lipid peroxides (33).  280 
Hence, to provide additional evidence supporting the DCF fluorometric assays results, we 281 
measured the expression of OxyR as an independent indicator of oxidative stress. OxyR belongs 282 
to the LysR family of transcription factors whose regulon is involved in the cellular response to 283 
oxidative stress (22). OxyR is very sensitive to ROS concentrations, it is activated at very low 284 
hydrogen peroxide concentrations leading to upregulation to its regulon (34). Moreover, 285 
expression of oxyR is upregulated in response to hydrogen peroxide using lacZ promoter fusions 286 
(35); similarly, another LysR-type transcription regulator involved in the response to oxidative 287 
stress is overexpressed in response to ROS (36). Therefore, we constructed derivatives of wild 288 
type and mutant strains carrying an oxyR::lux promoter fusion to measure oxyR gene expression 289 
at chromosomal levels. PmB stimulated the oxyR expression (Fig. 4A), which was consistent 290 
with the induction of intracellular ROS detected by DCF (Fig. 1 and 3). Likewise, catalase 291 
activity, regulated by OxyR (22), increased in response to PmB (Table 2). This further confirms 292 
the induction of intracellular ROS in response to PmB and validates the findings of DCF 293 
fluorometric and oxyR expression assays as measures of intracellular ROS.  oxyR expression was 294 
significantly higher in ∆BCAL2641 compared to the parental strain both in the presence or 295 
absence of PmB. In contrast, no difference in oxyR expression between the wild type and 296 
∆BCAM1111-BCAM1112 was detected in response to PmB (Fig. 4A). No differences in the 297 
growth rate of the different strains were noted in absence of PmB; whereas ∆BCAL2641 was 298 
more susceptible to PmB compared to the wild type and ∆BCAM1111-BCAM1112 (Fig. S2). 299 
These results follow the same pattern of ROS generated in response to PmB in the mutants 300 
compared to the wild type strain (Fig. 3).  301 
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 Next, we investigated the mechanism by which putrescine protects from oxidative stress. 302 
Putrescine stimulated the expression of oxyR (Fig. 4A), probably as a result of a slight induction 303 
of ROS accumulation as detected by DCF (Fig. 1). However, putrescine alleviated the increase in 304 
oxyR expression in response to PmB (Fig. 4A), suggesting a protective effect against ROS. 305 
Nevertheless, putrescine did not induce a statistically significant difference in growth of the wild 306 
type in the presence or absence of PmB at this early time point of incubation (3 h) under the 307 
conditions of this test (Fig. S2). Supporting the protective role of putrescine from oxidative 308 
stress, we confirmed the antioxidant properties of putrescine by demonstrating that it could 309 
scavenge superoxide radicals generated in vitro from a phenazine methosulfate-NADH system in 310 
a concentration dependent manner (Fig. 4B). Together, the results of this section reveal a link 311 
between reduced susceptibility to PmB, induction of ROS production, and expression of OxyR 312 
with the intracellular level of putrescine, which can be attributed to the antioxidant properties of 313 
this polyamine. 314 
 Expression of the putrescine synthesis enzymes in response to PmB. To better understand 315 
the role of the different putrescine synthesizing enzymes in response to oxidative stress and 316 
consequently to PmB, we investigated the expression profiles of their corresponding genes also 317 
using lux promoter fusions as before. BCAL2641::lux gene expression was stimulated by 318 
exposure to PmB (Fig. 5A); whereas neither BCAM1111::lux nor BCAM1112::lux fusions were 319 
responsive to PmB (Fig. 5B and 5C respectively). This agrees with the behaviour of 320 
∆BCAL2641 and ∆BCAM1111-BCAM1112 mutants to PmB in terms of antimicrobial 321 
resistance (Fig. 2C-2E) and ROS production (Fig. 3). Moreover, this is consistent with our 322 
previous data showing increased transcription of BCAL2641, but not BCAM1111 or 323 
BCAM1112, in response to PmB (12). BCAL2641 also appears to regulate by an unknown 324 
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mechanism the gene expression of BCAM1111 and BCAM1112 putrescine synthesis enzymes, 325 
since the expression of both genes was significantly reduced in the ∆BCAL2641 background 326 
(Fig. 5B and 5C, respectively). This regulation is not mediated through the action of putrescine 327 
since 10 mM of putrescine did not stimulate the gene expression of BCAM1111 or BCAM1112 328 
(not shown). Other indirect regulatory pathways may be involved which will require further 329 
investigation. On the other hand, the gene expression of BCAL2641 increased in the absence of 330 
BCAM1111 and BCAM1112 (Fig. 5A), which may explain the slight increase in survival of the 331 
∆BCAM1111-BCAM1112 when exposed to PmB shown in Fig. 2E. This might be due to 332 
compensation of the reduced synthesis of putrescine by these enzymes being normally stimulated 333 
by BCAL2641. Alternatively, BCAM1111 and BCAM1112 might provide feedback inhibition to 334 
BCAL2641; thus their absence would lead to increased BCAL2641 gene expression. Notably, 335 
the expression of BCAM1112 (RLU/OD600 0.2423) is much lower than that of the other 2 336 
enzymes (RLU/OD600 1.4829 and 1.5585 for BCAL2641 and BCAM1111 respectively). This 337 
suggests that B. cenocepacia does not preferentially utilize the arginine decarboxylase 338 
BCAM1112. This agrees with the fact that B. cepacia can degrade arginine only through the use 339 
of the succinyl transferase pathway, despite the possession of an arginine decarboxylase 340 
homologue (37, 38). Except for ∆BCAL2641, which exhibited reduced growth in the presence of 341 
PmB, no differences in growth were observed in the other strains tested regardless of PmB 342 
exposure (Fig. S3). Together, our findings expose BCAL2641 as a crucial contributor of 343 
putrescine synthesis in the response against antibiotics. 344 
 ROS production in response to other bactericidal antibiotics. To evaluate whether the 345 
induction of oxidative stress and its amelioration by putrescine is a general phenomenon, we 346 
tested other bactericidal antibiotics. Exposure of B. cenocepacia to gentamicin, norfloxacin, 347 
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ceftazidime and rifampicin led to increased ROS production as detected by DCF (Fig. S4) at sub-348 
lethal concentrations; i.e. concentrations below but more specifically near the MIC of these 349 
antibiotics (Fig. S5). Putrescine reduced the antibiotic-induced elevation in ROS levels only for 350 
norfloxacin and rifampicin (Fig. 6), and this correlated with induction of BCAL2641 gene 351 
expression (Fig. 7A and 7B, respectively). This agrees with the contribution of BCAL2641 in 352 
resistance to both antibiotics that we have previously reported (12). Moreover, oxyR transcription 353 
was also upregulated in response to both norfloxacin and rifampicin (Fig. 7A and 7B, 354 
respectively), which was reflected in an increase in the catalase activity (Table 2), supporting the 355 
notion that both antibiotics lead to increased ROS production (Fig. 6 and Fig. S4). In contrast, 356 
neither antibiotic affected BCAM1111 gene expression (Fig. 7), indicating that this gene and its 357 
product are not directly involved in the response to antibiotic-mediated oxidative stress. It should 358 
be noted that higher rifampicin concentrations resulted in great reduction in the expression of 359 
BCAL2641, oxyR, and BCAM1111 (Fig. 7B), which might be attributed to non-specific 360 
inhibition of transcription by rifampicin, especially at 512 µg/ml where expression from these 361 
genes was almost completely inhibited.  362 
 Putrescine did not reduce ROS production generated in response to ceftazidime, but rather 363 
further increased the generated ROS at 10 mM but not at 20 mM concentration of putrescine 364 
(Fig. 6). Ceftazidime did not affect the expression of BCAL2641, oxyR or BCAM1111 (Fig. 7C), 365 
and did not alter the catalase enzyme activity (Table 2). However, in a previous study we 366 
reported that BCAL2641 is involved in the response of B. cenocepacia to ceftazidime (12). This 367 
may suggest another role of BCAL2641 in the protective actions against ceftazidime not related 368 
to the oxidative stress. 369 
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 Concerning the response to gentamicin, exogenous putrescine did not affect the level of 370 
gentamicin-induced superoxide anion (Fig. 6). Moreover, gentamicin did not alter the expression 371 
of BCAL2641 (Fig. 7D). This agrees with the previously reported lack of involvement of this 372 
enzyme in the response to gentamicin in B. cenocepacia (12). Furthermore, gentamicin did not 373 
affect the expression of oxyR (Fig. 7D). However, the highest tested concentrations of 374 
gentamicin did reduce the expression of both BCAL2641 and oxyR (Fig. 7D). Similarly, 375 
gentamicin reduced the catalase enzyme activity (Table 2). Such inhibition might be due to the 376 
mechanism of action of the aminoglycoside inhibiting translation and protein synthesis in 377 
general, since it also inhibited the expression of BCAM1111, which consequently might have led 378 
to increased ROS levels at high concentration (Fig. 6).  379 
 Conclusions. We show that: (i) sub-lethal concentrations of different bactericidal antibiotics 380 
(PmB at 1 mg/ml, rifampicin at 256 and 512 µg/ml and norfloxacin at 32 and 64 µg/ml) induce 381 
oxidative stress in B. cenocepacia that is manifested as induction of ROS formation as detected 382 
by DCF, stimulation of expression of the transcription regulator OxyR involved in response to 383 
oxidative stress (at antibiotic concentrations similar to or even lower than those inducing ROS 384 
formation; PmB at 0.5 mg/ml, rifampicin at 16 and 32 µg/ml and norfloxacin at 16-64 µg/ml), 385 
and increased catalase enzyme activity (PmB at 0.5 mg/ml, rifampicin at 16 µg/ml and 386 
norfloxacin at 8 µg/ml); (ii) this response does not apply to gentamicin and ceftazidime which do 387 
not induce OxyR expression or increase catalase enzyme activity, suggesting that not all 388 
bactericidal antibiotics induce oxidative stress; (iii) putrescine protects against oxidative stress 389 
induced by several bactericidal antibiotics (PmB, norfloxacin and rifampicin); (iv) protection by 390 
putrescine correlates with increased BCAL2641 gene expression; (v) BCAL2641, in addition to 391 
synthesizing putrescine, regulates the other putrescine biosynthetic enzymes BCAM1111 and 392 
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BCAM1112 by an unknown mechanism that does not directly involve putrescine. Together, 393 
these observations suggest a model (Fig. 8) by which B. cenocepacia responds to antibiotic stress 394 
by overproducing putrescine and in turn, this polyamine protects bacterial cells by a surface 395 
effect blocking antibiotic binding (12) as well as by reducing oxidative damage. 396 
 Putrescine was previously shown to communicate antibiotic resistance among different 397 
bacteria (12). Its increased production in B. cenocepacia occurs in response to a subset of 398 
bactericidal antibiotics (12), which induce oxidative stress in bacterial cells at near lethal 399 
concentration ranges. It is still controversial whether the generation of ROS is the cause of 400 
lethality of antimicrobial agents or a consequence of antibiotic stress (16, 20, 21). However, it is 401 
conceivable that the oxidative stress accompanying antibiotic treatment imposes a metabolic 402 
burden on the bacterial cells at near death conditions. Thus, our results demonstrating a 403 
protective role for putrescine in the response to the oxidative stress generated in B. cenocepacia 404 
during antibiotic exposure represent another mechanism of protection from the antibacterial 405 
effects of bactericidal antibiotics. This agrees with previous reports on the antioxidant properties 406 
and protective effects of putrescine against antibiotic induced ROS formation in E. coli (17). 407 
 While little is known about the physiological levels of putrescine, it seems that its level 408 
varies in different body sites. For example, putrescine concentration was reported to be 3 mM in 409 
urine (11), whereas it was shown to be up to 0.2 mM in sputum samples from CF patients (39, 410 
40). However, it is difficult to predict the local concentration of putrescine and other polyamines 411 
in the lung of CF patients, as infection alters the rheology of the mucus and the lung environment 412 
(41). Moreover, putrescine levels increase dramatically (by 10 fold or more) during 413 
exacerbations of bacterial infections in CF patients (39, 40). Hence, the concentrations used in 414 
this study could potentially resemble the physiological situation in certain body compartments. 415 
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Furthermore, a direct relationship exists between increased putrescine concentration during 416 
infection and the proliferation of lung microbiota and specific pathogens such as P. aeruginosa 417 
in the lungs of CF patients (40). Also, putrescine and other polyamines in genital mucosal fluids 418 
increase the resistance of N. gonorrhoeae to antimicrobial peptides (PmB and LL-37), possibly 419 
enhancing its survival during infection by reducing bacterial susceptibility to host-derived 420 
antimicrobials (11). Interestingly, the expression of the ornithine decarboxylase BCAL2641 is 421 
induced in B. cenocepacia in CF conditions compared to soil environmental like conditions 422 
shown by comparative transcriptomics, underscoring the importance of putrescine, and this 423 
enzyme in particular, during infection (42). 424 
 This study also provides new information on the regulation of the putrescine synthesis 425 
enzymes. The ornithine decarboxylase BCAL2641 gene responds to the external antibiotic 426 
signals, while the other ornithine decarboxylase BCAM1111 or the arginine decarboxylase 427 
BCAM1112 do not. Also, BCAL2641 regulates the expression of BCAM1111 and BCAM1112 428 
since their expression depends on the presence of BCAL2641. This suggests that upon antibiotic 429 
stress maximal production of putrescine is required, which arises from the upregulation of 430 
BCAL2641 and by maintaining the expression of the other two enzymes in a BCAL2641-431 
dependent manner. The molecular mechanism of this regulation awaits further investigation.   432 
 In conclusion, this study broadens our understanding on the mechanism of chemical 433 
communication of antibiotic resistance mediated by putrescine. In addition, it provides a clear 434 
target for the design of inhibitors targeting the ornithine decarboxylase BCAL2641 that is 435 
critically implicated in this phenomenon. Such inhibitors would not only reduce the resistance to 436 
antibiotics in B. cenocepacia but also would reduce its ability to communicate high-level 437 
resistance to other less resistant bacteria. 438 
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TABLE 1 Strains and Plasmids 446 
Strain    Relevant characteristicsa            Source and/or  447 
or plasmid                    reference 448 
 449 
Strains 450 
Burkholderia cenocepacia 451 
K56-2   ET12 clone related to J2315, CF clinical Isolate,  bBCRRC    (43) 452 
OME11  K56-2, ∆BCAL2641             (12) 453 
OME12  K56-2, ∆BCAM1111-∆BCAM1112          (12) 454 
OME49  OME12 Prha::BCAL2641            This study 455 
OME50  K56-2, PBCAL2641::pGSVTp-luxCDABE; TpR        This study 456 
OME51  OME12, PBCAL2641::pGSVTp-luxCDABE; TpR       This study 457 
OME52  K56-2, PBCAM1111::pGSVTp-luxCDABE; TpR        This study 458 
OME53  OME11, PBCAM1111::pGSVTp-luxCDABE; TpR       This study 459 
OME54  K56-2, PBCAM1112::pGSVTp-luxCDABE; TpR        This study 460 
OME55  OME11, PBCAM1112::pGSVTp-luxCDABE; TpR       This study 461 
OME56  K56-2, PoxyR::pGSVTp-luxCDABE; TpR         This study 462 
OME57  OME11, PoxyR::pGSVTp-luxCDABE; TpR        This study 463 
OME58  OME12, PoxyR::pGSVTp-luxCDABE; TpR        This study 464 
 465 
Escherichia coli  466 
DH5α   F-φ80lacZ M15 endA1 recA1 supE44 hsdR17(rK- mK+)deoR thi-1 nupG  Laboratory 467 
    supE44 gyrA96relA1 ∆(lacZYA-argF)U169, λ-        stock 468 
GT115   F– mcrA∆(mrr-hsdRMS-mcrBC) φ80∆lacZ∆M15 ∆lacX74 recA1   Invivogen 469 
    rpsL(StrA) endA1∆dcm uidA(∆MluI)::pir-116 ∆sbcC-sbcD     470 
 471 
Plasmids 472 
 473 
pRK2013  oricolE1, RK2 derivative, KanR, mob+, tra+         (26) 474 
pGSVTp-lux Mobilizable suicide vector containing the lux operon, derivative from  475 
    pGSV3-lux (44); OriT; TpR            (45) 476 
pSC200  oriR6K, PRhaB rhamnose-inducible promoter, TpR, mob+     (28) 477 
pOE14   PBCAL2641::luxCDABE transcriptional fusion in pGSVTp-lux    This study 478 
pOE17   Prha::BCAL2641 in pSC200            This study 479 
pOE18   PBCAM1111::luxCDABE transcriptional fusion in pGSVTp-lux    This study 480 
pOE19,   PBCAM1112::luxCDABE transcriptional fusion in pGSVTp-lux    This study 481 
pOE20   PoxyR::luxCDABE transcriptional fusion in pGSVTp-lux     This study 482 
 483 
aTpR, trimethoprim resistance, KanR, kanamycin resistance, TetR, tetracycline resistance. 484 
bBCRRC, B. cepacia Research and Referral Repository for Canadian CF Clinics. 485 
 486 
 487 
 488 
 489 
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TABLE 2 Catalase enzyme activities. 490 
Antibiotic Concentration   Catalase Activity*  Difference from control 491 
  (µg/ml)      % Units/OD600 (SEM)   (P-value) 492 
None       100 (1.3)     Not applicable 493 
Polymyxin B (500)    120.1 (4.2)       0.0002 494 
Norfloxacin (8)     110.6 (1.2)       0.0012 495 
Rifampicin (16)     134.5 (5.2)     <0.0001 496 
Ceftazidime (32)     99.8 (12. 4)       0.978 (Not significant) 497 
Gentamicin (1000)    48.0 (7.1)     <0.0001 498 
* Results from 2 independent experiments, n=6. r2 of calibration curves was: 0.9644 and 0.9544. 499 
 500 
  501 
 502 
 503 
 504 
 505 
 506 
 507 
 508 
 509 
 510 
 511 
 512 
 513 
 514 
 515 
516 
 24
REFERENCES 517 
1. Ejim L, Farha MA, Falconer SB, Wildenhain J, Coombes BK, Tyers M, Brown ED, 518 
Wright GD. 2011. Combinations of antibiotics and nonantibiotic drugs enhance 519 
antimicrobial efficacy. Nat Chem Biol 7:348-350. 520 
2. Waters V. 2012. New treatments for emerging cystic fibrosis pathogens other than 521 
Pseudomonas. Curr Pharm Des 18:696-725. 522 
3. Loutet SA, Valvano MA. 2010. A decade of Burkholderia cenocepacia virulence 523 
determinant research. Infect Immun 78:4088-4100. 524 
4. Corey M, Farewell V. 1996. Determinants of mortality from cystic fibrosis in Canada, 525 
1970-1989. Am J Epidemiol 143:1007-1017. 526 
5. Speert DP, Henry D, Vandamme P, Corey M, Mahenthiralingam E. 2002. 527 
Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. 528 
Emerg Infect Dis 8:181-187. 529 
6. Chen JS, Witzmann KA, Spilker T, Fink RJ, LiPuma JJ. 2001. Endemicity and inter-530 
city spread of Burkholderia cepacia genomovar III in cystic fibrosis. J Pediatr 139:643-531 
649. 532 
7. De Soyza A, Ellis CD, Khan CM, Corris PA, Demarco de Hormaeche R. 2004. 533 
Burkholderia cenocepacia lipopolysaccharide, lipid A, and proinflammatory activity. Am 534 
J Respir Crit Care Med 170:70-77. 535 
8. El-Halfawy OM, Valvano MA. 2012. Non-genetic mechanisms communicating 536 
antibiotic resistance: Rethinking strategies for antimicrobial drug design. Expert Opinion 537 
On Drug Discovery 7:923-933. 538 
 25
9. Smith AL, Fiel SB, Mayer-Hamblett N, Ramsey B, Burns JL. 2003. Susceptibility 539 
testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic 540 
administration: lack of association in cystic fibrosis. Chest 123:1495-1502. 541 
10. Peters BM, Jabra-Rizk MA, O'May GA, Costerton JW, Shirtliff ME. 2012. 542 
Polymicrobial interactions: impact on pathogenesis and human disease. Clin Microbiol 543 
Rev 25:193-213. 544 
11. Goytia M, Shafer WM. 2010. Polyamines can increase resistance of Neisseria 545 
gonorrhoeae to mediators of the innate human host defense. Infect Immun 78:3187-3195. 546 
12. El-Halfawy OM, Valvano MA. 2013. Chemical communication of antibiotic resistance 547 
by a highly resistant subpopulation of bacterial cells. PLOS One 8:e68874. 548 
13. Tabor CW, Tabor H. 1984. Polyamines. Annu Rev Biochem 53:749-790. 549 
14. Wortham BW, Patel CN, Oliveira MA. 2007. Polyamines in bacteria: pleiotropic 550 
effects yet specific mechanisms. Adv Exp Med Biol 603:106-115. 551 
15. Johnson L, Mulcahy H, Kanevets U, Shi Y, Lewenza S. 2012. Surface-localized 552 
spermidine protects the Pseudomonas aeruginosa outer membrane from antibiotic 553 
treatment and oxidative stress. J Bacteriol. 554 
16. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. 2007. A common 555 
mechanism of cellular death induced by bactericidal antibiotics. Cell 130:797-810. 556 
17. Tkachenko AG, Akhova AV, Shumkov MS, Nesterova LY. 2012. Polyamines reduce 557 
oxidative stress in Escherichia coli cells exposed to bactericidal antibiotics. Res 558 
Microbiol 163:83-91. 559 
 26
18. Kolodkin-Gal I, Sat B, Keshet A, Engelberg-Kulka H. 2008. The communication 560 
factor EDF and the toxin-antitoxin module mazEF determine the mode of action of 561 
antibiotics. PLOS Biol 6:e319. 562 
19. Choi H, Lee DG. 2012. Synergistic effect of antimicrobial peptide arenicin-1 in 563 
combination with antibiotics against pathogenic bacteria. Res Microbiol 163:479-486. 564 
20. Keren I, Wu Y, Inocencio J, Mulcahy LR, Lewis K. 2013. Killing by bactericidal 565 
antibiotics does not depend on reactive oxygen species. Science 339:1213-1216. 566 
21. Liu Y, Imlay JA. 2013. Cell death from antibiotics without the involvement of reactive 567 
oxygen species. Science 339:1210-1213. 568 
22. Imlay JA. 2008. Cellular defenses against superoxide and hydrogen peroxide. Annu Rev 569 
Biochem 77:755-776. 570 
23. Sambrook J, Fritsch EF, Maniatis T. 1990. Molecular cloning: a laboratory manual, 571 
2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. 572 
24. Cohen SN, Chang AC, Hsu L. 1972. Nonchromosomal antibiotic resistance in bacteria: 573 
genetic transformation of Escherichia coli by R-factor DNA. Proc Natl Acad Sci U S A 574 
69:2110-2114. 575 
25. Craig FF, Coote JG, Parton R, Freer JH, Gilmour NJ. 1989. A plasmid which can be 576 
transferred between Escherichia coli and Pasteurella haemolytica by electroporation and 577 
conjugation. J Gen Microbiol 135:2885-2890. 578 
26. Figurski DH, Helinski DR. 1979. Replication of an origin-containing derivative of 579 
plasmid RK2 dependent on a plasmid function provided in trans. Proc Natl Acad Sci U S 580 
A 76:1648-1652. 581 
 27
27. Tkachenko AG, Fedotova MV. 2007. Dependence of protective functions of 582 
Escherichia coli polyamines on strength of stress caused by superoxide radicals. 583 
Biochemistry (Mosc) 72:109-116. 584 
28. Ortega XP, Cardona ST, Brown AR, Loutet SA, Flannagan RS, Campopiano DJ, 585 
Govan JR, Valvano MA. 2007. A putative gene cluster for aminoarabinose biosynthesis 586 
is essential for Burkholderia cenocepacia viability. J Bacteriol 189:3639-3644. 587 
29. Iwase T, Tajima A, Sugimoto S, Okuda K, Hironaka I, Kamata Y, Takada K, 588 
Mizunoe Y. 2013. A simple assay for measuring catalase activity: a visual approach. Sci 589 
Rep 3:3081. 590 
30. Rhee SG, Chang TS, Jeong W, Kang D. 2010. Methods for detection and measurement 591 
of hydrogen peroxide inside and outside of cells. Mol Cells 29:539-549. 592 
31. Chou HT, Kwon DH, Hegazy M, Lu CD. 2008. Transcriptome analysis of agmatine 593 
and putrescine catabolism in Pseudomonas aeruginosa PAO1. J Bacteriol 190:1966-594 
1975. 595 
32. Renggli S, Keck W, Jenal U, Ritz D. 2013. The role of auto-fluorescence in flow-596 
cytometric analysis of Escherichia coli treated with bactericidal antibiotics. J Bacteriol. 597 
33. Kooy NW, Royall JA, Ischiropoulos H. 1997. Oxidation of 2',7'-dichlorofluorescin by 598 
peroxynitrite. Free Radic Res 27:245-254. 599 
34. Aslund F, Zheng M, Beckwith J, Storz G. 1999. Regulation of the OxyR transcription 600 
factor by hydrogen peroxide and the cellular thiol-disulfide status. Proc Natl Acad Sci U 601 
S A 96:6161-6165. 602 
35. Tkachenko AG, Nesterova LY. 2003. Polyamines as modulators of gene expression 603 
under oxidative stress in Escherichia coli. Biochemistry (Mosc) 68:850-856. 604 
 28
36. Reen FJ, Haynes JM, Mooij MJ, O'Gara F. 2013. A non-classical LysR-type 605 
transcriptional regulator PA2206 is required for an effective oxidative stress response in 606 
Pseudomonas aeruginosa. PLoS One 8:e54479. 607 
37. Vander Wauven C, Stalon V. 1985. Occurrence of succinyl derivatives in the 608 
catabolism of arginine in Pseudomonas cepacia. J Bacteriol 164:882-886. 609 
38. Stalon V, Mercenier A. 1984. L-arginine utilization by Pseudomonas species. J Gen 610 
Microbiol 130:69-76. 611 
39. Grasemann H, Shehnaz D, Enomoto M, Leadley M, Belik J, Ratjen F. 2012. L-612 
ornithine derived polyamines in cystic fibrosis airways. PLoS One 7:e46618. 613 
40. Twomey KB, Alston M, An SQ, O'Connell OJ, McCarthy Y, Swarbreck D, Febrer 614 
M, Dow JM, Plant BJ, Ryan RP. 2013. Microbiota and Metabolite Profiling Reveal 615 
Specific Alterations in Bacterial Community Structure and Environment in the Cystic 616 
Fibrosis Airway during Exacerbation. PLoS One 8:e82432. 617 
41. Laube BL, Sharpless G, Benson J, Carson KA, Mogayzel PJ, Jr. 2013. Mucus 618 
Removal Is Impaired in Children with Cystic Fibrosis Who Have Been Infected by 619 
Pseudomonas aeruginosa. J Pediatr. 620 
42. Yoder-Himes DR, Konstantinidis KT, Tiedje JM. 2010. Identification of potential 621 
therapeutic targets for Burkholderia cenocepacia by comparative transcriptomics. PLoS 622 
One 5:e8724. 623 
43. Mahenthiralingam E, Coenye T, Chung JW, Speert DP, Govan JR, Taylor P, 624 
Vandamme P. 2000. Diagnostically and experimentally useful panel of strains from the 625 
Burkholderia cepacia complex. J Clin Microbiol 38:910-913. 626 
 29
44. Moore RA, Reckseidler-Zenteno S, Kim H, Nierman W, Yu Y, Tuanyok A, Warawa 627 
J, DeShazer D, Woods DE. 2004. Contribution of gene loss to the pathogenic evolution 628 
of Burkholderia pseudomallei and Burkholderia mallei. Infect Immun 72:4172-4187. 629 
45. Bernier SP, Nguyen DT, Sokol PA. 2008. A LysR-type transcriptional regulator in 630 
Burkholderia cenocepacia influences colony morphology and virulence. Infect Immun 631 
76:38-47. 632 
 633 
Figure Legends 634 
 635 
FIG 1. Putrescine reduces ROS production induced by PmB in B. cenocepacia K56-2. ROS 636 
were detected by DCF. n= 6 from 2 independent experiments. 637 
 638 
FIG 2. BCAL2641 is the only putrescine synthesis enzyme in B. cenocepacia involved in 639 
reduced susceptibility to PmB. A. Putrescine synthesis pathway in B. cenocepacia K56-2 640 
together with the enzymes involved. ADC, arginine decarboxylase; ODC, ornithine 641 
decarboxylase. B. TLC plate showing the lack of production of putrescine in ∆BCAM1111-1112 642 
Prha-BCAL2641 conditional mutant under non-permissive conditions. Put, putrescine; Cad, 643 
cadaverine; Spd, spermidine; Spn, spermine. C-E. Sensitivity of wild type and putrescine 644 
synthesis mutants ∆BCAL2641 (OME11) and ∆BCAM1111-1112 (OME12) to 2048 µg/ml PmB 645 
determined turbidimetrically. n=3 from a representative experiment. C, low initial inoculum in 646 
LB medium; D, high initial inoculum in LB medium; D, in M9 minimal medium. 647 
 648 
FIG 3. BCAL2641 is the main ornithine decarboxylase responsible for reduction of ROS 649 
accumulation and reduced susceptibility to PmB. ROS production in response to 1 mg/ml PmB 650 
in wild type K56-2, compared to putrescine synthesis mutants ∆BCAL2641 (OME11) and 651 
∆BCAM1111-1112 (OME12) detected by DCF. n=6 from 2 independent experiments. 652 
 653 
FIG 4. A. Induction of OxyR expression as an indicator of ROS accumulation in the wild type 654 
(OME56) compared to putrescine synthesis mutants ∆BCAL2641 (OME57) and ∆BCAM1111-655 
1112 (OME58) in response to 500 µg/ml PmB with or without 10 mM Put determined by 656 
luciferase expression assay at 3 h. Results are shown as percentage of relative light units 657 
RLU/OD600 relative to the OME56 control (K56-2 background). The mean RLU/OD600 of the 658 
control is 0.09567. The percentages of OD600 are shown in Fig. S2. n=9 from 3 different clones. 659 
 30
* p<0.05, ** p<0.01 and *** p<0.001. B. In vitro antioxidant activity of putrescine. n=6 from 2 660 
independent experiments. 661 
 662 
FIG 5. Luciferase expression assay of the different putrescine synthesizing enzymes in response 663 
to 500 µg/ml PmB at 3 h. Results are shown as percentage of relative light units RLU/OD600 664 
relative to the control (untreated K56-2 background). The percentages of OD600 are shown in Fig. 665 
S3. A Expression of BCAL2641 in the wild type (OME50) and ∆BCAM1111-1112 (OME51) 666 
backgrounds. n=6 from 2 different clones. The mean RLU/OD600 of the control is 1.4829. B 667 
Expression of BCAM1111 in the wild type (OME52) and ∆BCAL2641 (OME53) backgrounds. 668 
n= 6 from 2 different clones. The mean RLU/OD600 of the control is 1.5585. C Expression of 669 
BCAM1112 in the wild type (OME54) and ∆BCAL2641 (OME55) backgrounds. n= 7 from 2 670 
different clones. The mean RLU/OD600 of the control is 0.2423. * p<0.05, ** p<0.01 and *** 671 
p<0.001. 672 
 673 
FIG 6. The role of putrescine in the bactericidal antibiotics-mediated ROS accumulation in B. 674 
cenocepacia K56-2. n= 9 from 3 independent experiments. The 4 tested antibiotics alone 675 
significantly (p<0.001) induced the accumulation of ROS compared to control cells. * p<0.05, ** 676 
p<0.01 and *** p<0.001. 677 
 678 
FIG 7. Effect of different antibiotics on the expression of BCAL2641 (in OME50), oxyR (in 679 
OME56), and BCAM1111 (in OME52) determined using a luciferase expression assay at 3 h. 680 
Results are shown as percentage of relative light units RLU/OD600 relative to the control 681 
(untreated K56-2 background). The percentages of OD600 are shown in Fig. S5. n= a minimum of 682 
6 from at least 2 different clones. The mean RLU/OD600 of the control is 1.0759 for BCAL2641; 683 
0.1087 for oxyR and 1.4723 for BCAM1111. * p<0.05, ** p<0.01 and *** p<0.001. 684 
 685 
FIG 8. Model summarizing the role of putrescine in protecting B. cenocepacia from antibiotic-686 
induced stress. 687 
 688 








